Sunshine Biopharma (SBFM) announced its Board of Directors has formally approved a strategic investment of $5M in Bitcoin (BTC-USD) as a strategic reserve asset. This move aligns with Sunshine Biopharma’s broader strategy to strengthen its financial foundation while advancing its pipeline of generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates. The Company’s Bitcoin investment of $5M will be executed over time through a regulated digital asset custodian or, the purchase of an ETF or a proxy stock. The Company plans to increase its holdings of Bitcoin by allocating additional funds as such funds become available in the future.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off